...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Rock Stars still rocking it
5
Jun 04, 2018 02:53PM
2
Jun 05, 2018 03:35PM
3
Jun 06, 2018 04:20AM
1
Jun 06, 2018 02:43PM

I've listened to the presentation twice and it sure gives me a feeling of hope.

In terms of cohort definitions Don's comments related to page 16 (Trial Design) in the top blue rectangle suggests 3 planned dosage levels all with the same enzalutimide dosage. So I assume the 5 chorts are dosage levels.

However, I did email Sarah and asked for specific definitions just to be sure.

It does seem quite positive.

I did not see or hear any indication that ZCC or ZEG will be sold in the next couple of months or that there will be liquidity soon.

Toinv

4
Jun 13, 2018 03:45PM
2
Jun 13, 2018 06:53PM
1
Jun 13, 2018 09:44PM
Share
New Message
Please login to post a reply